Pharmaceutically Licensed Plasma
octaplasLG® and octaplas® are human plasma for infusion of pharmaceutical grade with standardised quality and unique safety profiles due to their integrated pathogen safety concept that represents state-of-the-art security for patients.
The standardised content in octaplasLG® and octaplas® is achieved by pooling between 630 and 1520 single plasma units from multiple donors.
The safety measures present during the manufacturing include:
octaplasLG® and octaplas® are indicated in complex deficiencies of coagulation factors such as:
octaplasLG® and octaplas® are presented in 200 mL bags containing 9 - 14 g of ABO-blood group specific human plasma proteins (45 - 70 mg/mL).
They are supplied in separate presentations according to the following blood groups: A, B, AB, 0.
octaplasLG® and octaplas® must be stored and transported frozen (at ≤ -18°C) in the original package in order to protect from light. The shelf life is four years. In most European countries, five days stability after thawing has been approved.
1. octaplasLG® - Summary of product characteristics (EU)
2. octaplas® - Summary of product characteristics (EU)
You are now on Octapharma’s global website. Please select your country from the menu at the top of this page to access more detailed country-specific information or to contact your local Octapharma team.